Conversely, high levels of Notch1 underlaid SCLC chemoresistance to doxorubicin that was resolved by Notch1 knockdown, which once again points out the controversial role of Notch signaling in tumor onset and progression [160]. Here, NOTCH1 is linked to neoplasm.